A recent study published in the European Journal of Neuroscience provides new insights into how 3,4-methylenedioxymethamphetamine (MDMA), commonly known as ecstasy or molly, affects the brain’s ...
"The results suggest that oxytocin, rather than vasopressin, may play a key role in mediating the hyponatremic response to a ...
SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders ...
5mon
News Medical on MSNHigh-dose psilocybin shows promise for depression treatmentStudy: Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results